Provided is a chimeric antigen receptor NK cell expressing specific recognition for GPC3 and preparation method therefor, as well as a use of the cell in prevention and/or treatment of cancers, especially a GPC3-expression cancer. Also provided is a use of the NK cell as a targeting cell therapeutic agent and/or in adoptive immunotherapy of cancers.